A comparison of the growth of Leishmania mexicana in IL‐4–/–, IL‐4Rα–/– and wild‐type BALB/c mice demonstrated a disease exacerbative role for IL‐13 as well as IL‐4. Thus, while both IL‐4–/– and IL‐4Rα–/– mice were more resistant than wild‐type controls to infection with L. mexicana, IL‐4Rα–/– mice, which are unresponsive to IL‐13 as well as IL‐4, were significantly more resistant to parasite growth than their IL‐4–/– counterparts. Cytokine and antibody analysis revealed a Th1‐biased specific response in both infected IL‐4–/– and IL‐4Rα–/– mice compared with wild‐type animals. Reconstituting SCID mice with IL‐4–/–, IL‐4Rα–/– or wild‐type splenocytes prior to infection demonstrated that the early onset of lesion growth was dependent on the presence of lymphocytes responding to IL‐4 and/or IL‐13, as lesions failed to develop in only the SCID IL‐4Rα–/– reconstituted mice. An independent role for IL‐13 in L. mexicana infection was demonstrated by comparing disease progression in IL‐13–/–, IL‐4–/–/IL‐13–/– and wild‐type B6/129 mice. In contrast to IL‐4–/–/IL‐13–/– mice, which were resistant, IL‐13–/– mice developed lesions similar in size to wild‐type animalsup to week 8 post infection. However, in contrast to wild‐type mice in which disease continued to progress, lesions eventually healed in IL‐13–/– mice, in association with the development of a Th1 response. Collectively our results suggest that IL‐4 plays a critical role in early lesion development, and that IL‐13 plays a crucial part in maintaining a chronic non‐healing infection.